ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
•09 Nov 2017 16:52

Korea, Kospi 200: Targeting 400+

The MSCI Asia Free ex-Japan (MXASJ – 703) regional benchmark, is expected to exceed 1,080 before the bull market that started in 2016 ends, that’s...

Logo
260 Views
Share
•06 Nov 2017 00:54

Samsung Electronics Common-Pref Spread - Data & Situational Study

Let's do one interesting study here. In the last month (Oct 10-Nov 3), Samsung Electronics Pref Shares (005935 KS) ranked fifth in the local...

Logo
444 Views
Share
bullish•SK Telecom
•09 Oct 2017 03:05

SK Group Restructuring - Local Institutions Are Already Making A Move

We are now seeing a very interesting move from Korea's local institutions on those SK Group restructuring stocks. Last week, to be specific from...

Logo
433 Views
Share
•05 Oct 2017 22:59

Foreign Investors Vs. Local Institutions in Korean Stock Market - Who Is Right?

Last month, foreign investors went on a buying spree in the Korea's second largest stock market, KOSDAQ. In contrast, they went on a selling spree...

Logo
1.2k Views
Share
bearish•Samsung Biologics
•04 Oct 2017 00:25

Biosimilar Battlefield: U.S. Humira Pushed to 2023

We are updating our market model to reflect the patent litigation settlement between Amgen Inc (AMGN US) and Abbvie Inc (ABBV US) , the...

Share
x